Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2267]

FDA approves asciminib for Philadelphia chromosome-positive chronic myeloid leukaemia

FDA approves asciminib for Philadelphia chromosome-positive chronic myeloid leukaemia

Vulnerable populations not receiving cancer survivorship care plans

Vulnerable populations not receiving cancer survivorship care plans

Nivolumab + chemotherapy receives European commission approval for patients with HER2 negative, advanced or metastatic gastric, gastroesophageal junction or oesophageal adenocarcinoma

Nivolumab + chemotherapy receives European commission approval for patients with HER2 negative, advanced or...

Challenges and recommendations for real-world evidence in oncology: Focus on Central and Eastern Europe

Challenges and recommendations for real-world evidence in oncology: Focus on Central and Eastern Europe

FDA approves atezolizumab as adjuvant treatment for non-small cell lung cancer

FDA approves atezolizumab as adjuvant treatment for non-small cell lung cancer

Pembrolizumab and lenvatinib receive positive EU CHMP opinions for two different types of cancer

Pembrolizumab and lenvatinib receive positive EU CHMP opinions for two different types of cancer

First worldwide personalized-medicine study using a functional test demonstrates clinical feasibility and efficacy of individualised therapy in leukaemia and lymphoma patients

First worldwide personalized-medicine study using a functional test demonstrates clinical feasibility and efficacy...

FDA recognises Memorial Sloan-Kettering database of molecular tumour marker information

FDA recognises Memorial Sloan-Kettering database of molecular tumour marker information

Study establishes the value of cardiovascular magnetic resonance imaging for suspected cardiac tumours

Study establishes the value of cardiovascular magnetic resonance imaging for suspected cardiac tumours

Inhibition of the aurora kinase a protein may help overcome lung cancer resistance to KRAS inhibition

Inhibition of the aurora kinase a protein may help overcome lung cancer resistance to KRAS inhibition

More from ecancer